Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-10

FDA Approved: PIOGLITAZONE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva's pioglitazone generic (Original Application) for type 2 diabetes mellitus. This marks the approval of a generic version as an alternative to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)

Snippet

ORIG AP for PIOGLITAZONE (PIOGLITAZONE)